Stay updated on Tucatinib Combo in HER2+ LMD Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Combo in HER2+ LMD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Combo in HER2+ LMD Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now identifies the site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-03T23:13:42.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    A sitewide notice about NIH terminology changes appears, and the website revision updates from v3.7.1 to v3.7.2.
    Difference
    0.7%
    Check dated 2026-10-20T22:38:09.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-06T22:35:06.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    A new site revision v3.7.0 was added to the history, and the older revision v3.6.6 was removed from the list.
    Difference
    0.1%
    Check dated 2026-09-15T20:42:24.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 appears in the history and the previous entry v3.6.5 is removed. This reflects an update to the page's revision log rather than changes to the trial data or content.
    Difference
    0.2%
    Check dated 2026-09-01T18:26:49.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The history now shows a termination update due to FDA approval, marking the study as terminated and ending accrual. This reflects a final status for the record and informs readers that enrollment and further results reporting are concluded.
    Difference
    0.1%
    Check dated 2026-08-25T19:44:03.000Z thumbnail image

Stay in the know with updates to Tucatinib Combo in HER2+ LMD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo in HER2+ LMD Clinical Trial page.